Page 6 - Diabetes

50% surge in diabetes in individuals under 40 yrs of age, say experts

India is often dubbed as the diabetic capital of the world where nearly 11 per cent of the population is grappling with the disease

Karwa Chauth: All you need to know about fasting tips for diabetic women

Karwa Chauth is a delightful and sacred Hindu Celebration. In India, particularly in Northern parts of India, women fast from sunrise to moonrise for the well-being and long life of their spouses

Prefer deductible to co-pay in senior citizen health insurance cover

Last week Tata AIG General Insurance launched a plan for this group, adding to the considerable number of plans already available

Biocon, Juno Pharma ink pact for commercialisation of Liraglutide in Canada

Under the agreement's terms, Biocon will be responsible for obtaining regulatory approvals for Liraglutide and will subsequently manage the manufacturing and distribution of the product within Canada

Natural light may help treat and prevent type 2 diabetes: Research

Exposure to natural light may help treat and prevent type 2 diabetes, according to a small study. The research, presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Germany from October 2-6, carried out a range of metabolic tests on a group of people with type 2 diabetes when they were exposed to natural light and when they were exposed to artificial light and compared the results. "The misalignment of our internal circadian clock with the demands of a 24/7 society is associated with an increased incidence of metabolic diseases, including type 2 diabetes," said Ivo Habets of Maastricht University, the Netherlands, who co-led the research. "Natural daylight is the strongest zeitgeber, or environmental cue, of the circadian clock, but most people are indoors during the day and so under constant artificial lighting," said Habets. The yet-to-be peer-reviewed study involved 13 participants with an average age of 70 years who stayed in research

Implantable device could allow injection-free diabetes management: Study

The study was published in Proceedings of the National Academy of Science

Dr Reddy's Lab launches generic diabetes medication in US market

Dr Reddy's Laboratories on Thursday said it has launched a generic diabetes medication in the US market. The drug major has launched Saxagliptin and Metformin Hydrochloride extended-release tablets in the US market, the Hyderabad-based company said in a statement. The company's product is a therapeutic equivalent generic version of Kombiglyze XR tablets, it added. Dr Reddy's Saxagliptin and Metformin Hydrochloride extended-release tablets are supplied in a strength of 2.5 mg/1000 mg in bottle count of 60 and strengths of 5 mg/500 mg and 5 mg/1000 mg each in bottle counts of 30, the company said.

Akums Drugs gets DCGI nod for triple combination diabetes medication

Akums Drugs and Pharmaceuticals on Thursday said it has received approval from the Drug Controller General of India (DCGI) for triple combination diabetes medication. Sitagliptin 100, Pioglitazone 15 and Metformin 1000/500 have been combined for the treatment of diabetes and offers a number of pharmacological advantages, the company said in a statement. The combination drug is going to better serve anti-diabetic patients, who require better treatment without necessarily swallowing multiple drugs. Akums Drugs & Pharmaceuticals Joint Managing Director Sandeep Jain noted that the renoprotective effects of drugs like metformin, coupled with the functional and corrective influence of pioglitazone on beta-cell and metabolic syndrome and the stability of Sitagliptin, make an effective solution for diabetes. "As a brand, we will continue to introduce new combinations to help patients around the world get better," he added.

Deep sleep improves body's response to insulin, key to regulate blood sugar

An increased responsiveness of the human body to insulin during deep sleep, in turn, improving blood sugar control the next day, may be why lack of quality sleep is considered to increase risk of diabetes, researchers say. A stronger and a more frequent linking of the deep sleep brain waves, particularly the sleep spindles and the slow waves, triggered the body's parasympathetic nervous system into action, the researchers from the University of California (UC) Berkeley, US, found after examining sleep data of 600 individuals. The parasympathetic branch of the nervous system is associated with soothing and calming the body by producing physiological effects such as slowing down the heart and dilating blood vessels. The researchers detected this shift in the participants by measuring changes in their heart rate. Further, they found that switching to this tranquil and calm mode enhanced the body's responsiveness to insulin, the blood sugar-regulating hormone, which instructs cells to

Medicines for anxiety, diabetes to get cheaper as NPPA fixes ceiling prices

If drug manufacturers are found flouting the ceiling, they will have to deposit the overcharged amount with the Centre

Diabetes a pandemic, needs vaccines, efficacious medication for control

It is estimated that 101 million people in India - around 10 per cent of the country's population - are suffering from diabetes

Want immediate insurance coverage for diabetes? Apply for a customised plan

Though costlier, they offer coverage for both type I and II diabetes, and to those with high levels of HbA1C

Race to develop weight-loss pills has some drugmakers falling behind

Novo and Lilly's experimental obesity pills helped people lose about 15% of body weight, similar to weight-loss shots on the market already, according to findings presented

Pfizer to discontinue development of obesity drug due to side effects

Pfizer has been developing treatments to target weight loss in diabetes and obesity patients, as it races to target a market estimated to reach $100 billion by the end the of decade

Eli Lilly's Mounjaro gives positive results in obese diabetic people

Diabetes occurs when the body loses the ability to control blood sugar, and it's one of the world's most common serious diseases

Diabetic Term Plan for HbA1c < 8 by Bajaj Allianz Life

Bajaj Allianz Life Insurance has launched a term insurance product specifically designed for individuals with type II diabetes and pre-diabetes, says Chief Distribution Officer Dheeraj Sehgal.

Top headlines: Adani draws scrutiny in US, 1.3 bn to have diabetes globally

Business Standard brings you the top headlines at this hour

Over 1.3 billion people globally to have diabetes by 2050, finds study

A loss of the body's ability to control blood sugar levels, diabetes affects one in 10 adults globally and caused 6.7 million deaths in 2021, the International Diabetes Federation estimates

Diabetes cases on a rise in India: Understanding Type 1 and Type 2 diabete

Type 1 diabetes is seen most often in children and young adults, although the disease can occur at any age, but it is less common than type 2 diabetes

Cheap diabetes drug could cut risk of developing long coronavirus: Study

The study involved 1,126 overweight and obese people who were randomly assigned to receive either metformin or a placebo within three days of testing positive for Covid-19